Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan
Journal of Veterinary Pharmacology and Therapeutics · 2026
DOI: 10.1111/jvp.70051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2026. Verfasst von Juhana M Honkavaara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland. Hauptthemen laut MEDLINE: Adrenergic alpha-2 Receptor Antagonists, Analgesics, Opioid, Butorphanol, Imidazoles. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Finnish Veterinary Foundation, Vetcare, Eläinlääketieteen Tutkimuksen Tukisäätiö.
Abstract (Originalsprache)
The aim of the study was to determine the exposure to subcutaneously administered butorphanol in horses pre‐treated with intravenous (IV) detomidine, with or without vatinoxan, a peripherally selective alpha 2 ‐adrenoceptor antagonist. Five healthy, adult horses received three IV treatments 7 days apart, in a randomized, cross‐over design: detomidine 20 μg/kg (DET‐B), detomidine 20 μg/kg with vatinoxan 200 μg/kg (DETVAT‐B) and saline (S‐B), all followed by 0.1 mg/kg of butorphanol administered subcutaneously 30 min later. Venous samples were collected between 10 and 270 min after butorphanol administration. Butorphanol concentrations in plasma were analyzed with liquid chromatography coupled with triple quadruple mass spectrometry. Data were analyzed with non‐compartmental methods. The observed areas under plasma butorphanol concentration‐time curves were 8104 ± 2590, 7042 ± 2628 and 5996 ± 1670 ng·min/mL for DET‐B, DETVAT‐B and S‐B, respectively. There were no significant differences between treatments. Pre‐treatment with detomidine, with or without vatinoxan, did not significantly affect the exposure to subcutaneously administered butorphanol in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland.
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
- Admescope (Symeres Finland OY), Oulu, Finland.
ORCID-Profile: Juhana M Honkavaara, Bruno H Pypendop, Marja R Raekallio
Förderung
- The Finnish Veterinary Foundation
- Vetcare
- Eläinlääketieteen Tutkimuksen Tukisäätiö
Zitieren
APA
Honkavaara, J. M., Karikoski, N. P., Palvas, L., Pypendop, B. H., Rinne, V. M., & Raekallio, M. R. (2026). Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70051
Vancouver
Honkavaara JM, Karikoski NP, Palvas L, Pypendop BH, Rinne VM, Raekallio MR. Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70051
BibTeX
@article{Honkavaara2026,
author = {Honkavaara, Juhana M and Karikoski, Ninja P and Palvas, Laura and Pypendop, Bruno H and Rinne, Valtteri M and Raekallio, Marja R},
title = {Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/jvp.70051}
}
EUVIMED